Adaptive TCR Corporation

SEATTLE, WA 98102

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $2.66MM
First Award Date 08/01/10
Most Recent Award Date 11/01/16

Key Personnel

Last Name Name Awards Contact
Livingston Robert J Livingston 3
Robins Harlan S. Robins 3
Rieder Mark J Rieder 4
Delaney Colleen Delaney 2

7 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 11/01/16 - 10/31/17

DESCRIPTION (provided by applicant): Many patients requiring stem cell transplantation for hematological malignancies are unable to find a suitable HLA-matched sibling or unrelated donor. Transplants using stem cells from umbilical cord blood provide an alternative for these patients, allowing transplantation to proceed with less stringent HLA-m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 06/01/14 - 05/31/15

DESCRIPTION (provided by applicant): The purpose of this proposal is to adapt a technology that we have developed for monitoring residual disease in leukemia patients to monitor residual autoimmune disease in Celiac Disease patients. Celiac disease has a significant burden on quality of life, as it is one of the most frequent autoimmune disea...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/10/13 - 05/31/14

DESCRIPTION (provided by applicant): Many patients requiring stem cell transplantation for hematological malignancies are unable to find a suitable HLA-matched sibling or unrelated donor. Transplants using stem cells from umbilical cord blood provide an alternative for these patients, allowing transplantation to proceed with less stringent HLA-m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 06/24/13 - 12/23/13

DESCRIPTION (provided by applicant): Minimal Residual Disease Monitoring by T-cell Receptor Repertoire Profiling T-cell neoplasms are generally more aggressive and have poorer outcomes than comparable B-cell lymphomas. In addition, for many of these patients, prognosis following disease relapse is dismal. Detecting the presence or absence of Min...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 08/01/11 - 01/31/12

DESCRIPTION (provided by applicant): The goal of this Phase I project is to develop a method to objectively measure immune reconstitution following hematopoietic stem cell transplantation using direct sequencing of the T-cell repertoire. This method will be developed using data from patients treated with stem cells derived from umbilical cord b...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-114
Budget: 08/01/11 - 07/31/12

DESCRIPTION (provided by applicant): The goal of this Phase I project is the identification of a molecular signature in the T-cell receptor repertoire of early-stage Type 1 Diabetes (T1D) patients that distinguishes these patients from controls. At present, immunomodulatory therapies have not proven useful for treatment of T1D, largely because ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-114
Budget: 08/01/10 - 07/31/11

DESCRIPTION (provided by applicant): The goal of this Phase I project is the identification of a molecular signature in the T-cell receptor repertoire of early-stage Type 1 Diabetes (T1D) patients that distinguishes these patients from controls. At present, immunomodulatory therapies have not proven useful for treatment of T1D, largely because ...